Cellulose biomembrane versus collagenase dressing for the treatment of chronic venous ulcers: a randomized, controlled clinical trial.

Cellulose biomembranes may be used for difficult-to-treat ulcers. To assess the efficacy and safety of cellulose biomembranes compared to a collagenase dressing for the treatment of chronic venous ulcers. A randomized, controlled clinical trial was performed using two groups: one treated with collagenase dressing and the other with cellulose biomembrane over a 90-day (T90) period.

Nanoskin® to treat full thickness skin wounds.

This experimental study evaluated 40 guinea pigs that received Nanoskin®. A full thickness skin rectangle measuring 2x4 cm was removed from the median dorsal region and the wound was covered by a 2X2 cm fragment of uncoated Nanoskin® graft (uncoated group) or Nanoskin® coated with gelatin (coated group) and sutured in the caudal region and a 2x2 cm fragment of autologous skin sutured in the cranial aspect of the surgical wound served a control. The animals were examined daily by ectoscopy and euthanized at 7, 30, 90 and 180 days postoperatively.

Surface physical chemistry properties in coated bacterial cellulose membranes with calcium phosphate.

Bacterial cellulose has become established as a new biomaterial, and it can be used for medical applications. In addition, it has called attention due to the increasing interest in tissue engineering materials for wound care. In this work, the bacterial cellulose fermentation process was modified by the addition of chondroitin sulfate to the culture medium before the inoculation of the bacteria.

Nanoskin® Subcutaneous Implant in Guinea Pigs.

Purpose: To evaluate the suitability of Nanoskin, a biomaterial derived from bacterial cellulose, as an alternate material for repairing the posterior lamellae of the eyelids.

Methods: Forty guinea pigs received a fragment of Nanoskin subcutaneously in the dorsal region. The animals received Nanoskin (group 1) or Nanoskin coated with a gelatin layer (group 2).

Novel chemically modified bacterial cellulose nanocomposite as potential biomaterial for stem cell therapy applications.

Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of applied scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of hyaluronic acid and gelatin (1% w/w) to the culture medium before the bacteria is inoculated. Hyaluronic acid and gelatin influence in bacterial cellulose was analyzed using Transmission Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM).